These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1396946)

  • 1. BCG therapy in superficial bladder tumours--complications and precautions.
    Steg A; Adjiman S; Debré B
    Eur Urol; 1992; 21 Suppl 2():35-40. PubMed ID: 1396946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.
    Paterson DL; Patel A
    Aust N Z J Surg; 1998 May; 68(5):340-4. PubMed ID: 9631906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
    Gonzalez OY; Musher DM; Brar I; Furgeson S; Boktour MR; Septimus EJ; Hamill RJ; Graviss EA
    Clin Infect Dis; 2003 Jan; 36(2):140-8. PubMed ID: 12522745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
    Leebeek FW; Ouwendijk RJ; Kolk AH; Dees A; Meek JC; Nienhuis JE; Dingemans-Dumas AM
    Gut; 1996 Apr; 38(4):616-8. PubMed ID: 8707098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic bacillus-Calmette Guerin infection after transurethral administration for superficial bladder carcinoma.
    Sakamoto GD; Burden J; Fisher D
    J Urol; 1989 Oct; 142(4):1073-4; discussion 1074-5. PubMed ID: 2795734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular and other serious infections with Mycobacterium bovis after bacillus of Calmette-Guérin therapy for bladder cancer.
    Hellinger WC; Oldenburg WA; Alvarez S
    South Med J; 1995 Dec; 88(12):1212-6. PubMed ID: 7502112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
    Sosnowski JT
    Compr Ther; 1994; 20(12):695-701. PubMed ID: 7882653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Granulomatous hepatitis and sepsis secondary to intravesical instillation of bacillus Calmette-Guérin].
    Garmilla-Ezquerra P; Martínez-De Las Cuevas G; Hernández-Hernández JL
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):656-7. PubMed ID: 22683174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary tuberculosis caused by Mycobacterium bovis BCG variety, following intravesical instillation].
    Cameo MI; Lezcano MA; Gil D; Blas M
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):134-5. PubMed ID: 19695743
    [No Abstract]   [Full Text] [Related]  

  • 11. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
    Harding GE; Lawlor DK
    J Vasc Surg; 2007 Jul; 46(1):131-4. PubMed ID: 17606130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe bacillus Calmette-Guerin cystitis responds to systemic steroids when antituberculous drugs and local steroids fail.
    Wittes R; Klotz L; Kosecka U
    J Urol; 1999 May; 161(5):1568-9. PubMed ID: 10210404
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of complications of bacillus Calmette-Guérin immunotherapy in the treatment of bladder cancer.
    Huang TC
    Ann Pharmacother; 2000 Apr; 34(4):529-32. PubMed ID: 10772442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG-related granulomatous hepatitis.
    Hristea A; Neacsu A; Ion DA; Streinu-Cercel A; Stăniceanu F
    Pneumologia; 2007; 56(1):32-4. PubMed ID: 17491206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy].
    Raffray L; Rivière P; Bonnet H; Duffau P; Longy-Boursier M
    Rev Med Interne; 2015 Sep; 36(9):626-30. PubMed ID: 25467298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication.
    Calleris G; Marra G; Corcione S; Oderda M; Cardellino C; Audagnotto S; Frea B; De Rosa FG; Gontero P
    Infez Med; 2017 Dec; 25(4):366-370. PubMed ID: 29286018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.
    Nadasy KA; Patel RS; Emmett M; Murillo RA; Tribble MA; Black RD; Sutker WL
    South Med J; 2008 Jan; 101(1):91-5. PubMed ID: 18176300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granulomatous pneumonia as a complication of intravesical BCG immunotherapy--a case report].
    Rogoziński P; Taracha-Guz D; Pęcikiewicz P; Kachel T; Dubiel G; Wandzel P; Bruliński K
    Pneumonol Alergol Pol; 2014; 82(2):163-9. PubMed ID: 24615200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical approaches to the prevention and treatment of adverse reactions to BCG.
    van der Meijden AP
    Eur Urol; 1995; 27 Suppl 1():23-8. PubMed ID: 7750529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium bovid infection of total knee arthroplasty after bacille Calmette-Guérin therapy for bladder cancer.
    Rispler DT; Stirton JW; Gilde AK; Kane KR
    Am J Orthop (Belle Mead NJ); 2015 Feb; 44(2):E46-8. PubMed ID: 25658082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.